Skip to main content
Top
Published in: Breast Cancer Research 2/2005

01-06-2005 | Oral Presentation

Insulin-like growth factor regulation of mammary gland development and tumorigenesis

Published in: Breast Cancer Research | Special Issue 2/2005

Login to get access

Excerpt

Insulin-like growth factors (IGFs) are potent mitogens and survival factors. In the mammary gland, IGFs stimulate proliferation, differentiation, and survival during numerous developmental stages; IGF signaling is required for puberty-dependent ductal outgrowth, stimulates lobuloalveolar development during pregnancy, and is reduced or absent during apoptosis-driven involution. Much of our knowledge of IGF action in the mammary gland in vivo comes from knockout or transgenic models. However, very few of these studies have examined the consequence of these gene alterations on IGF signaling in vivo. We have recently shown that intravenous injection of IGF-I stimulates IGF-IR and IRS phosphorylation in the mammary gland, and we are currently assessing the effect of targeted gene deletion of overexpression of IGF signaling components on downstream signaling in the mammary gland in vivo. …
Metadata
Title
Insulin-like growth factor regulation of mammary gland development and tumorigenesis
Publication date
01-06-2005
Published in
Breast Cancer Research / Issue Special Issue 2/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1066

Other articles of this Special Issue 2/2005

Breast Cancer Research 2/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine